Idorsia
Carmela Gnerre has extensive experience in the field of non-clinical pharmacokinetics and drug metabolism, holding several leadership positions at prominent pharmaceutical companies. At Idorsia Pharmaceuticals Ltd from June 2017 to November 2023, Carmela served as Senior Director and Deputy Head of Non-Clinical Pharmacokinetics and Drug Metabolism. Prior to this, Carmela spent over a decade at Actelion, progressing through roles including Director and Associate Director, while also leading teams in non-clinical pharmacokinetics and drug metabolism. Earlier, Carmela worked as a Research Scientist at Biozentrum, University of Basel. Academically, Carmela earned a Ph.D. in Pharmaceutical Sciences and a Diploma in Pharmacy from the University of Lausanne.
This person is not in any teams
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.